Nursing News

Effort seeks to increase the number of trained rheumatology nurse practitioners and physician assistants

Due to an aging population and increasing prevalence of rheumatic disease, there are growing demands on clinicians who specialize in rheumatology. To meet these demands, the American College of Rheumatology has developed a formal curriculum for nurse practitioners (NPs) and physician assistants (PAs). The curriculum is described in Arthritis Care & Research.

The development of a formal NP/PA curriculum outline in rheumatology is novel and can serve as a tool when adding NPs/PAs into clinical rheumatology practice. No other medical specialty has yet created an endorsed, standardized training tool that can aid in the preparation of NPs/PAs in a medical specialty.

"The Rheumatology Curriculum Outline is a practical tool that can be utilized in various adult and pediatric practice settings," said lead author Benjamin J. Smith, of Florida State University College of Medicine School of Physician Assistant Practice. "We anticipate that it will be used broadly to positively affect rheumatology workforce challenges."

Wiley, April 19, 2018 (tB).

Overcome key challenges in daily diabetes therapy

Integration of latest technology and Personalised Diabetes Management promotes improved outcomes and more time in range

  • Only 6.5% of people with diabetes in Europe reach their therapy targets1
  • Clinical inertia is a key contributor to this and needs to be overcome2 – in a joint effort of physicians, people with diabetes, healthcare systems and industry
  • Latest study evidence shows that integrating innovative technologies and the structured therapy approach of Personalised Diabetes Management improves therapy outcomes and contributes to a better overall glycemic control3
  • An open ecosystem approach with integrated diabetes management solutions addresses clinical inertia and promotes the achievement of more time in range.

Vienna, Austria (February 14, 2018) - Despite all technological innovations of the past years, still only 6.5% of people living with diabetes in Europe are able to achieve their individual therapy targets. Research shows that this can mainly be attributed to multiple factors described as clinical inertia, which includes patient, physician and system-related factors such as e.g. disease denial, medication issues, depression, poor health literacy, too little time in the doctor’s office or poor communication.4 Experts reckon clinical inertia to contribute to people with diabetes living with suboptimal glycemic control for many years, with dramatic consequences in terms of quality of life, morbidity and mortality. This also has a huge impact on the healthcare system due to the high costs associated with uncontrolled diabetes.5

Obesity seen as self-inflicted

Berlin, Germany (February 2, 2018) - Representative survey in Germany, the UK, and the US: Although experts attribute the worldwide increase in obese people primarily to environmental changes, the general public lays the blame on individuals. In their opinion, those suffering from obesity should pay for any resulting medical expenses themselves. This is shown in a current study by the Max Planck Institute for Human Development and the University of Mannheim, published in Annals of Behavioral Medicine.

Late-Breaking Data Presented at IHC Highlight Primary and Secondary Outcome Measure Results from Chronic and Episodic Migraine Phase III Clinical Trials

Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine

Jerusalem, Israel (September 9, 2017) – Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) has presented new data evaluating fremanezumab, an investigational treatment for the prevention of migraine, at the 18th Congress of the International Headache Society (IHC) in Vancouver, Canada. Data presented across two platform presentations and five late-breaking abstracts featured detailed positive efficacy results from pivotal Phase III HALO studies of fremanezumab in chronic (CM) and episodic migraine (EM), as well as data from patient-reported outcomes tools in the chronic migraine trial.

More than 35 presentations and sessions showcase Shire’s gene therapy pipeline and leading factor portfolio: Shire to present new data at ISTH 2017 to advance the standard of care in haemophilia

Zug, Switzerland (June 23, 2017) – Shire plc (LSE: SHP, NASDAQ: SHPG), a leading biotechnology company focused on serving individuals with rare diseases, will present research covering a broad range of rare bleeding disorders at the 26th Biennial International Society on Thrombosis and Haemostasis Congress (ISTH), July 8-13, 2017 in Berlin, Germany. Showcased in eight oral presentations, 29 poster presentations and three symposia, these data underscore Shire’s pursuit of treatment innovation rooted in safety, efficacy, and individualized care for hemophilia patients.


Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2016

  • Seven medicines recommended for authorisation, 81 overall in 2016

London, GB (December 16, 2016) - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended seven new medicines for marketing authorisation at its December 2016 meeting. This brings the total number of medicines recommended for approval by the CHMP in 2016 to 811.

Nine medicines recommended for approval, including three biosimilars

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2016

London, GB (November 11, 2016) - The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended nine medicines for approval at its November meeting. The CHMP recommended granting a marketing authorisation for Afstyla (lonoctocog alfa) for the prevention and treatment of bleeding in patients with haemophilia A.

Toward a hand-held 'breathalyzer' for diagnosing diabetes

Washington, DC, USA (November 9, 2016) - For several years, scientists have been working toward "breathalyzers" that can diagnose various diseases without painful pinpricks, needles or other unpleasant methods. Now, one team has developed a new, portable breath analyzer that could someday help doctors diagnose diabetes noninvasively in the office. The report appears in the ACS journal Analytical Chemistry.

WHO recommends 29 ways to stop surgical infections and avoid superbugs

Geneva, Switzerland November 3, 2016) - People preparing for surgery should always have a bath or shower but not be shaved, and antibiotics should only be used to prevent infections before and during surgery, not afterwards, according to new guidelines from WHO that aim to save lives, cut costs and arrest the spread of superbugs.

New Guideline on Management of Older Patients with CKD

(November 2, 2016) - In the industrialized world, the average age of dialysis patients is constantly rising. People have now a significantly higher life expectancy than 50 years ago, and chronic kidney disease (CKD) is a disease that often occurs in older age. The CKD and dialysis populations are aging, thus posing new challenges for nephrology. Older patients have more comorbidities, a different physiology and, of course, a shorter life expectancy. The latter aspect, especially, may impact therapeutic decisions, for example whether renal replacement therapy should be initiated or conservative treatment be maintained.

Hospital readmission history a valid measure of skilled nursing quality

PROVIDENCE, R.I., USA (November 1, 2016) --When an elderly loved one is discharged from a hospital to a skilled nursing facility (SNF), the family's hope is that they will get good care that will allow them to return home rather than poor care that requires a return trip to the hospital. That's why on its Nursing Home Compare website, the federal government recently included an SNF's historical track record of 30-day hospital readmissions in its ratings of care quality.

Pic.: The aim of OPTIMISTIC -- an acronym for Optimizing Patient Transfers, Impacting Medical quality and Improving Symptoms: Transforming Institutional Care -- is to improve care and communication within nursing facilities and between these facilities and acute-care institutions. Credit: Indiana University Center for Aging Research OPTIMISTIC study

Advance care planning in nursing homes challenging but critical

INDIANAPOLIS , Indiana, USA (November 1, 2016) - The goal of advance care planning is to ensure that the health care an individual receives is consistent with his or her values and preferences. New research shows the critical need for advance care planning and highlights the challenges that healthcare institutions -- especially nursing homes -- face in supporting high quality advance care planning.

Pembrolizumab (KEYTRUDA) Checkpoint Inhibitor for the treatment of patients with metastatic non-small cell lung cancer (NSCLC)

Silver Springs, MD, USA (October 25, 2016) - On October 24, 2016, the U.S. Food and Drug Administration approved pembrolizumab (KEYTRUDA, Merck & Co., Inc.) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express PD-L1 as determined by an FDA-approved test.


Thousands of melanoma patients in Europe have no access to new life saving drugs

COPENHAGEN, Denmark (October 7, 2016 ) - Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen1. Metastatic melanoma is an aggressive and deadly skin cancer. With innovative targeted therapy and immunotherapy, patients can survive for many years. Unfortunately new therapies are expensive so, according to a survey conducted by Dr Lidija Kandolf-Sekulovic, over 5000 patients with metastatic melanoma in Europe have no access to these drugs.

Researchers look at the role of bacteria in incontinence

Weethinking the role of bacteria in incontinence

Lausanne, Switzerland (October 7, 2016) - We all know that feeling of suddenly needing to pee, and the agonizing worry that we might not find a toilet in time or make it that far. Sadly, for many people this is a regular occurrence and wetting themselves uncontrollably is an inevitable consequence. Almost 1 in 5 women over the age of 44 suffer from what is known as Urgency Urinary Incontinence (UUI): experiencing a strong sensation of an urgent need to pee, followed by immediate leakage of a large volume of urine. It can severely adversely affect someone's life, contributing to anxiety, depression and social isolation.

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2016

  • Eleven medicines recommended for approval, including three medicines for cancer

London, UK (September 16, 2016) - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended eleven medicines for approval at its September meeting. The CHMP recommended granting a conditional marketing authorisation for Lartruvo (olaratumab) for the treatment of adults with advanced soft tissue sarcoma. Lartruvo is to be used in combination with doxorubicin (a chemotherapy medicine) in patients with advanced soft tissue sarcoma for whom surgery or radiotherapy is not suitable, and who have not been previously treated with doxorubicin. Lartruvo was reviewed under EMA’s accelerated assessment mechanism and has an orphan designation. For more information, please see the press release in the grid below.

Accu_Chek Insight CGM app. Photo and Copyright: RocheUnique features and innovative design

Roche Diabetes Care’s new Accu-Chek® Guide wireless blood glucose monitoring system offers smart solutions for easier testing

                                    • Accuracy surpasses the ISO 15197:2013/EN ISO 15197:201510 requirements for blood glucose monitoring systems
                                    • Easy-to-use with an intuitive user interface and improved testing experience
                                    • Connectivity to the Accu-Chek Connect diabetes management system enables online data exchange with healthcare professionals and caregivers

Munich, Germany (September 12, 2016) - On August 31, 2016, Roche Diabetes Care received clearance by the U.S. Food and Drug Administration (FDA) for the new Accu-Chek Guide blood glucose monitoring system that has been designed to address previously unmet needs of patients and their healthcare professionals. The Accu-Chek Guide system offers a combination of unique features and an innovative design which make it easy and safe to use.

Innovation for relief

Roche Diabetes Care presents new solutions to re-define daily diabetes management

  • New Accu-Chek Guide blood glucose (BG) monitoring system offers easy testing experience, advanced accuracy1.2 and wireless connectivity to a mobile app and cloud-based diabetes management system.
  • New Accu-Chek Insight CGM system provides accuracy and reliability especially in the important hypoglycemic range and phases of fast changing glucose values.3
  • Integrated and personalised solutions are key to ease the management of diabetes in everyday routines and achieve improved therapy outcomes.

Munich, Germany (September 12, 2016) - Daily diabetes management can be stressful and cumbersome for people with diabetes. Moreover, despite the technologies currently available to handle the condition every day, over 50% of people with diabetes who have access to care still do not reach their therapy targets4.

Researchers call for an updated pain scale

Care providers underestimate pain during pediatric burn dressing change

Columbus, Ohio, USA (September 1, 2016) - Dressing changes have been identified as one of the major contributors to perceived pain during burn care, and so it is important that pain be assessed accurately. But a new study from the Center for Pediatric Trauma Research at Nationwide Children's Hospital suggests that pediatric burn pain assessment can vary not only based on patient pain intensity, but also nurse clinical experience.

New study finds connection between chronic pain and anxiety disorders

Burlington, Vermont, USA (August 31, 2016) - New research provides insight into a long-observed, but little-understood connection between chronic pain and anxiety and offers a potential target for treatment. The study's findings, published as an Article in Press in Biological Psychiatry, show that increased expression of PACAP - a peptide neurotransmitter the body releases in response to stress - is also increased in response to neuropathic pain and contributes to these symptoms.

Researchers predict onset of Alzheimer's disease with 85 percent accuracy

Major step towards Alzheimer's blood test

Cardiff, UK (August 31, 2016) - A research team, led by Cardiff University, has made a significant step towards the development of a simple blood test to predict the onset of Alzheimer's disease. Funded by the Alzheimer's Society, the group of researchers from Cardiff University, King's College London and the University of Oxford studied blood from 292 individuals with the earliest signs of memory impairment and found a set of biomarkers (indicators of disease) that predicted whether or not a given individual would develop Alzheimer's disease.

Hospitals should prepare simple standardized treatment protocols for early recognition and treatment of sepsis

Simple measures cut sepsis deaths nearly in half

Nord-Trøndelag, Norway (August 31, 2016) - Researchers were able to cut the number of patients who died from sepsis, or infections that spread to the bloodstream, by 40% (from 12.5% to 7.1%) after the introduction of relatively simple steps at the wards at Levanger Hospital in Nord-Trøndelag, Norway. The steps, which included increased training and a special observation chart, were introduced as part of a research project carried out by Nord University, Levanger Hospital, and the Mid-Norway Centre for Sepsis Research at NTNU and St. Olavs Hospital in Trondheim, Norway.

Digital forms of da ting violence are on the rise - what school nurses need to know

GALVESTON, Texas , USA (August 25, 2016) - Many teens experience physical or sexual abuse within their romantic relationships and now dating violence can also be perpetrated digitally by harassing, stalking or controlling a romantic partner via technology and social media. School nurses are often some of the first to identify such problems and play an active role in preventing them from happening in the first place. They are also in a natural position to act as first responders for victims of an abusive romantic relationship. Information on how school nurses can help these teens experiencing cyber abuse is described in a recent article in NASN School Nurse.

As online and offline forms of dating violence often go together, it is critical that school nurses are able to identify different types of digital dating violence. Digital dating abuse was also found to be associated with online bullying.

"School nurses can prepare for this task by being aware and making others aware that online and offline behaviors are becoming increasingly blurred in teens' lives and that digital dating abuse may be a warning sign of traditional abuse," said Jeff Temple, co-author of the paper and The University of Texas Medical Branch associate professor in the department of obstetrics and gynecology. "Most importantly, school nurses can engage in conversations with students about digital dating abuse, safe Internet use and healthy relationships, letting students know that they can come to them if they encounter online or offline dating violence."

In order to provide credible advice to teens, Temple says that it's important that school nurses are able to speak adolescents' language. They should become familiar and stay connected with advances in technology and popular social media apps.

Cyber dating abuse conversations could focus on what constitutes healthy communication within a romantic relationship and what signals could lead to abuse.

"Potential red flags can be identified, such as sharing pin codes and passwords to phones and apps, excessive contacting or demanding a partner to send a picture of where they are or whom they are with to 'prove' that they are telling the truth," Temple said. "Because of their inexperience with romantic relationships, teens might not know how to appropriately cope with feelings of uncertainty about their relationship and may resort to monitoring as a coping mechanism."

Also, some teens do not always identify abusive behaviors as such, instead considering them to be simply annoying.

Previous investigations have found that 26 percent of surveyed high school students reported being a victim of cyber dating abuse and 12 percent reported having perpetrated cyber dating abuse. Of these students, 9 percent of the teens reported that they were both victim and perpetrator of cyber dating abuse.

In previous studies, Temple also has found that victims of cyber dating abuse are more likely to binge drink, be sexual active, and participate in risky behavior.

Other authors include Joris Van Ouytsel, Michel Walrave and Koen Ponnet from the University of Antwerp, Belgium.

University of Texas Medical Branch at Galveston , 25.08.2016 (tB).

Charité researchers present a new study on the use of stroke emergency mobile ambulance

Is prehospital stroke treatment associated with better outcomes?

Berlin, Germany (August 25, 2016) - When treating a patient with stroke, every minute counts. A specialized stroke ambulance (Stroke Emergency Mobile or STEMO) allows physicians to start specific treatment, such as thrombolysis, at scene. A recent study conducted by researchers from Charité - Universitätsmedizin Berlin investigated whether this earlier response time leads to an improved prognosis. Patients who received the appropriate treatment during transfer to the hospital were less likely to have a disability three months after their stroke than patients who received conventional treatment. Although the difference in surviving without any disability slightly failed to reach the predefined level of significance, other outcomes such as severe disability or death were also more favorable in the STEMO group. Results from this study have been published in the journal The Lancet Neurology*.

Delirium in older patients after surgery may lead to long-term cognitive decline

BOSTON, USA ( July 14, 2016 ) -- Researchers from the Harvard Medical School - affiliated Hebrew SeniorLife Institute for Aging Research (IFAR) have found increasing evidence that delirium in older surgical patients may be associated with long-term cognitive decline. Findings from the study were published today in the July 2016 issue of Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

Forty years of the Nurses' Health Study

An evidence goldmine with a long-lasting legacy

Ultimo NSW, Australia (July 14, 2016) - It started in 1976 as an investigation into the potential health consequences of oral contraceptives, but the long-running Nurses' Health Study has yielded increasingly greater benefits to scientific knowledge of health and disease, according to a paper published today in the journal Public Health Research & Practice .

Pasta is not fattening, quite the opposite

Pozzilli, Italy (July 5, 2016) - A research from I.R.C.C.S. Neuromed in Pozzilli, Italy, shows that, unlike popular beliefs, pasta consumption does not contribute to obesity; on the contrary: it is associated with a decrease in body mass index. In recent years pasta gained a bad reputation: it will fatten you. This led lots of people to limit its consumption, often as part of some aggressive "do it yourself" diets. Now a study conducted by the Department of Epidemiology, I.R.C.C.S. Neuromed in Pozzilli, Italy, does justice to this fundamental element of the Mediterranean diet, showing how pasta consumption is actually associated with a reduced likelihood of both general and abdominal obesity.

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 June 2016

  • Six new medicines, including one cell-based therapy, recommended for approval

London, UK (June 24, 2016) -The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended six new medicines, including one advanced therapy medicinal product (ATMP), for approval at its June meeting. The CHMP recommended granting a conditional marketing authorisation for the ATMP Zalmoxis as an adjunctive, or add-on, treatment for adult patients receiving a haploidentical haematopoietic stem cell transplant (HSCT) for types of blood cancer to aid immune reconstitution and reduce the risk of graft-versus-host disease. Zalmoxis has an orphan designation.

Seeing is believing

Visual triggers increase hand hygiene compliance

Charlotte, N.C., USA ( June 9, 2016 ) - Can you use the "ick factor" to get healthcare workers to clean their hands more often? Yes, according to a new study being presented on June 11 at the 43rd Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC) .

FDA approves new drug to treat multiple sclerosis

Silver Spring, MD, USA (May 31, 2016) - The U.S. Food and Drug Administration approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.

The dying child

Room for improvement in end-of-life care

Cincinnati, OH, USA ( May 27, 2016 ) - Many pediatricians and pediatric subspecialists believe that their clinical care extends from treating ill children through end-of-life care. However, are pediatricians actually meeting the needs of families and their dying child? In a new study scheduled for publication in The Journal of Pediatrics, researchers surveyed bereaved parents and found that pediatric end-of-life care needs improvement.

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 May 2016

  • Six medicines, including two combination therapies for chronic hepatitis C, recommended for approval

London, UK (May 27, 2016) - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended six medicines for approval at its May meeting. The CHMP recommended granting marketing authorisations in the European Union for two new combination therapies to treat chronic (long-term) hepatitis C, Epclusa (sofosbuvir / velpatasvir) and Zepatier (elbasvir / grazoprevir). For more information please see the press release in the grid below.

FDA approves first buprenorphine implant for treatment of opioid dependence

  • Expanded use and availability of medication-assisted treatment is a top priority of federal effort to combat opioid epidemic

Silver Spring, MD, USA (May 26, 2016) - The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.

ECDC Annual Epidemiological report

Syphilis infections on the rise in Europe

Solna, Sweden (May 18, 2016) - New data released in ECDC's Annual Epidemiological report show that since 2010, the overall syphilis rates have been going up across Europe, particularly among men. In 2014, the reported syphilis numbers were six times higher in men than in women. Almost two-thirds (63%) of the syphilis cases reported with information on transmission category were recorded in men who have sex with men (MSM).


Drug used for pain, anxiety may be linked to birth defects

MINNEAPOLIS, Minnesota, USA (May 18, 2016) - A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. The drug pregabalin is approved by the FDA to treat epilepsy, fibromyalgia and neuropathic pain, such as pain from diabetic neuropathy or pain after shingles or spinal cord injury. It is also used for generalized anxiety disorder and other mental health issues. This is called off-label prescribing.

'Fight or flight' biological response may contribute to fatigue

Chronic fatigue patients more likely to suppress emotions

WASHINGTON, USA (May 17, 2016) - Chronic fatigue syndrome patients report they are more anxious and distressed than people who don't have the condition, and they are also more likely to suppress those emotions. In addition, when under stress, they show greater activation of the biological "fight or flight" mechanism, which may add to their fatigue, according to new research published by the American Psychological Association.

Study debunks idea that physicians use less aggressive health care at end of life

Doctors don't die differently than anyone el se

AURORA, Colo. , USA (May 17, 2015) - A new study from researchers at the University of Colorado Anschutz Medical Campus appears to disprove the increasingly popular notion that doctors die differently than everyone else, using fewer interventions that often have little value. In fact, the researchers said, their national study found that physicians use more hospice care, spend more time in Intensive Care Units (ICUs) and just as much time in hospitals when compared to the rest of the population.

Attending religious services associated with lower risk of death in women

May 16, 2016 - Frequently attending religious services was associated with a lower risk of death for women from all causes, cardiovascular disease and cancer, according to a new study published online by JAMA Internal Medicine. Religious practice is common in the United States but the effects of religious practice on health are not clear.

Electronic monitoring can be one tool -- with important caveats

What studying hand-washing is teaching about compliance

St. Louis, MO, USA (May 11, 2016) - In a myriad of workplace settings, standard processes are key to a successful operation, ensuring efficiency and safety. For these processes to work, employees must comply. But what's the best way to go about enforcing that compliance, and sustain it? New research from Olin Business School at Washington University in St. Louis shows that motivating compliance with standard processes via electronic monitoring can be a highly effective approach, despite concerns about employee backlash. However, the research also highlights that managers cannot simply "monitor and forget," and that a long-term plan for supporting the retention of monitoring is critical. The findings were published online May 5 in Management Science.

Fairness at work can affect employees' health

Norwich, Norfolk, UK (May 11, 2016) - Employees' experiences of fairness at work can impact on their health, according to a new study involving the University of East Anglia (UEA). The researchers investigated whether perceptions of what they call 'procedural justice', such as the processes in place to decide on rewards, pay, promotion and assignments, are related to employees' health. They found that when perceptions of fairness changed, the self-rated health of employees also changed, for example those who experienced more fairness on average over the period studied reported better health.

Seven of top 10 most profitable US hospitals are nonprofit : Nonprofit hospitals earn substantial profits

Baltimore, MD, USA (May 2, 2016) - Seven of the 10 most profitable hospitals in the United States in 2013 - each earning more than $163 million in profits from patient care services -- were nonprofit hospitals, according to new research from the Johns Hopkins Bloomberg School of Public Health and Washington and Lee University. The findings, reported in the May issue of the journal Health Affairs, show that while the majority of U.S. hospitals lost money caring for patients, a small percentage earned large profits. The results raise questions about whether peculiarities in the payment systems or some other factors are creating these outsized winners.